Figure 1From: Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor Erythropoietin (EPO) promotes significant improvement in motor function in rats subjected to traumatic axonal injury with hypoxia (TAI + Hx), but not in traumatic axonal injury (TAI) alone. Rats were trained on the Rotarod task for 7 d prior to injury, then tested daily for 6 d after surgery and on every second day until 14 d. (A) The deficit observed after TAI and TAI + EPO rats was similar 1 d postinjury. TAI rats made a steady recovery and improved throughout the course of the 2-week testing period; however there was no additional improvement after EPO treatment. (B) Both TAI + Hx and TAI + Hx + EPO groups achieved identical rpm scores on the Rotarod until 4 d postinjury, from which point TAI + Hx + EPO rats were performing significantly better on the Rotarod by 6 d than TAI + Hx rats. By 10 d, TAI + Hx + EPO rats reached an rpm similar to sham, with this beneficial effect maintained out to the end of the testing period. Data shown as mean ± SEM. N at 1 day = 24/group; 2 to 6 days = 12/group; 8 to 14 days = 6/group. Data was analysed by 2-way ANOVA repeated measures with Bonferroni post hoc test, with a P value of <0.05 considered significant.Back to article page